Supplementary Figure 2 from Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the &lt;i&gt;Her2/neu&lt;/i&gt; Oncogene Product: &lt;i&gt;In vitro&lt;/i&gt; and &lt;i&gt;In vivo&lt;/i&gt; Studies